An article by our collaborator Irene Tarragó

I live with epilepsy and I’ve never believed that my testimony could help other people. But, since I started writing about my life and my experience in public, a lot of people have approached me to ask me about it. It is amusing how little is known about this disease and how people get scared when they are diagnosed and, even more, when they are young fathers and mothers and their son gets diagnosed with epilepsy. That’s when they need someone to calm them down and show them an example of how you can live with this disease.

We know that there are many types of epilepsy and some are controlled with medications, some are not, some are operable, others are not… But it is also true that 80% of people with epilepsy can live a normal life. This is why devices like the one from MJN Neuroserveis are so important for those people whose epilepsy is not controllable with medications or operable. Thank you very much on behalf of all of them.

80% of people with epilepsy can live a normal life

In a more personal way, in the last few days, I have had some health problems, nothing too serious… But it seems that I am completely recovered and I can continue writing these collaborations with the people from MJN Neuroserveis, among which are David, Salva, and Xavi who do a lot for people with epilepsy. Having this device project in mind to anticipate epileptic seizures is wonderful.

By the way, don’t miss the interesting article that it has been published in the newspaper El Mundo, I think they explain very well the work that the entire MJN team does.

That’s all, greetings, and until the next entry!

Leave a Reply

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.